TELA insider transaction filings
TELA Bio, Inc. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen TELA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Getz Heather C — Chief Executive Officer, Director | Purchase (P): 12,500 @ $0.66 | EDGAR |
| 2026-08-17 | 4 | Getz Heather C — Chief Executive Officer, Director | Purchase (P): 15,000 @ $0.70 | EDGAR |
| 2026-08-05 | 4 | Getz Heather C — Chief Executive Officer, Director | Grant/award (A): 500,000 @ $0 · Grant/award (A): 1,365,000 (derivative) @ $0 · Grant/award (A): 1,005,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Plovanic William J. — Director | Grant/award (A): 20,930 @ $0.79 | EDGAR |
| 2026-07-17 | 4 | Capper Joseph H — Director | Grant/award (A): 6,227 @ $0.79 | EDGAR |
| 2026-06-11 | 4 | Rocchio Betty Jo — Director | Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Plovanic William J. — Director | Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Capper Joseph H — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | NEELS GUIDO J — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | NOHRA GUY P — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | THOMAS PAUL — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Blizard Jeffrey — President | Grant/award (A): 86,000 @ $0 · Grant/award (A): 127,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Firestone Gregory A. — Chief Business Officer | Grant/award (A): 37,000 @ $0 · Tax withholding (F): 4,189 @ $0.72 · Tax withholding (F): 1,352 @ $0.77 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Smeykal Megan — Chief Accounting Officer | Grant/award (A): 32,850 @ $0 · Tax withholding (F): 795 @ $0.80 · Tax withholding (F): 1,590 @ $0.72 · Tax withholding (F): 423 @ $0.77 | EDGAR |
| 2026-02-24 | 4 | Talmo Paul — Chief Technology Officer | Grant/award (A): 57,000 @ $0 · Tax withholding (F): 3,385 @ $0.72 · Tax withholding (F): 4,061 @ $0.77 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Cuca Roberto — COO and CFO | Grant/award (A): 57,000 @ $0 · Tax withholding (F): 4,780 @ $0.72 · Tax withholding (F): 5,234 @ $0.77 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | KOBLISH ANTONY — Chief Executive Officer, Director | Grant/award (A): 176,000 @ $0 · Tax withholding (F): 12,494 @ $0.72 · Tax withholding (F): 11,631 @ $0.77 · Tax withholding (F): 3,900 @ $0.79 · Grant/award (A): 261,000 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | EW HEALTHCARE PARTNERS FUND 2, L.P. — 10% owner EW HEALTHCARE PARTNERS FUND 2-A, L.P. — 10% owner EW Healthcare Partners Fund 2 GP, L.P. — 10% owner EW Healthcare Partners Fund 2-UGP, LLC — 10% owner | Purchase (P): 3,604,000 @ $1.11 | EDGAR |
| 2025-11-03 | 4 | Plovanic William J. — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | Rocchio Betty Jo — Director | Grant/award (A): 11,925 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Firestone Gregory A. — Chief Commercial Officer | Tax withholding (F): 1,093 @ $1.86 | EDGAR |
| 2025-06-02 | 4 | Blizard Jeffrey — President | Grant/award (A): 104,800 @ $0 · Grant/award (A): 154,100 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Azarbarzin Kurt — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Blizard Jeffrey — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Burgess Vincent J — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | EVANS DOUGLAS G — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | COLLERAN LISA N — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | O'Brien Federica F. — Director | Grant/award (A): 7,950 @ $0 · Grant/award (A): 11,700 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Talmo Paul — Chief Technology Officer | Tax withholding (F): 190 @ $1.22 | EDGAR |
| 2025-04-02 | 4 | Smeykal Megan — Chief Accounting Officer | Tax withholding (F): 96 @ $1.22 | EDGAR |
| 2025-04-02 | 4 | Firestone Gregory A. — Chief Commercial Officer | Tax withholding (F): 119 @ $1.22 | EDGAR |
| 2025-04-02 | 4 | KOBLISH ANTONY — Chief Executive Officer, Director | Tax withholding (F): 384 @ $1.22 | EDGAR |
| 2025-02-25 | 4 | Cuca Roberto — COO and CFO | Grant/award (A): 57,000 @ $0 · Tax withholding (F): 5,234 @ $2.72 · Grant/award (A): 83,800 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Firestone Gregory A. — Chief Commercial Officer | Grant/award (A): 51,600 @ $0 · Tax withholding (F): 364 @ $2.72 · Tax withholding (F): 1,352 @ $2.72 · Tax withholding (F): 240 @ $2.65 · Grant/award (A): 75,900 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Talmo Paul — Chief Technology Officer | Grant/award (A): 38,100 @ $0 · Tax withholding (F): 4,061 @ $2.72 · Tax withholding (F): 1,049 @ $2.65 · Grant/award (A): 56,100 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Smeykal Megan — Chief Accounting Officer | Tax withholding (F): 1,590 @ $2.72 · Tax withholding (F): 423 @ $2.72 · Tax withholding (F): 539 @ $2.65 | EDGAR |
| 2025-02-25 | 4 | KOBLISH ANTONY — Chief Executive Officer, Director | Grant/award (A): 149,000 @ $0 · Tax withholding (F): 11,631 @ $2.72 · Tax withholding (F): 5,772 @ $2.65 · Grant/award (A): 219,000 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Smeykal Megan — Chief Accounting Officer | Grant/award (A): 9,400 @ $0 | EDGAR |
Recent 8-K events — TELA Bio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-11-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TELA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →